查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1966203

全球增生性瘢痕和瘢痕疙瘩治疗市场规模、份额、趋势和成长分析报告（2026-2034年）

Global Hypertrophic And Keloid Scar Treatment Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 137 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计到 2025 年，增生性瘢痕和瘢痕疙瘩治疗的市场规模将达到 92.4 亿美元，到 2034 年将达到 256.5 亿美元，2026 年至 2034 年的复合年增长率为 12.02%。

由于人们对美容和皮肤科治疗的意识不断提高，全球增生性瘢痕和瘢痕疙瘩治疗市场正在扩张。外科手术、烧烫伤和创伤的发生率不断上升，也推动了对疤痕管理解决方案的需求成长。微创手术和雷射治疗技术的进步正在改善治疗效果。消费者对美观的追求也进一步推动了市场成长。

关键成长要素包括皮质类固醇注射、冷冻疗法、硅胶贴片和雷射治疗等技术进步。在全球范围内，皮肤科诊所和美容中心的数量不断增加，提高了人们获得专业医疗服务的便利性。社群媒体的影响和可支配收入的成长也促使消费者寻求美容治疗。此外，再生医学的持续研究正在拓展治疗选择。

展望未来，由于非侵入性治疗和联合疗法的持续创新，预计市场将稳步成长。随着医疗基础设施的扩展，新兴市场有望展现出巨大的成长潜力。对皮肤病学研发投入的增加可望加速产品开发。在患者对有效且价格合理的疤痕治疗需求不断增长的推动下，市场预计将持续发展。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 渗透率和成长前景分析
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 市场机会
    • 市场挑战
  • 波特五力分析
  • PESTLE分析

第四章 全球增生性瘢痕与瘢痕疙瘩治疗市场：依瘢痕类型划分

  • 市场分析、洞察与预测
  • 肥大的
  • 瘢痕疙瘩

第五章 全球增生性瘢痕和瘢痕疙瘩治疗市场：依产品类型划分

  • 市场分析、洞察与预测
  • 外部雷射产品
  • 产品
  • 注射药物
  • 其他的

第六章 全球增生性疤痕和瘢痕疙瘩治疗市场：依最终用户划分

  • 市场分析、洞察与预测
  • 医院
  • 诊所
  • 其他的

第七章 全球增生性疤痕和瘢痕疙瘩治疗市场：依地区划分

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 南非
    • 其他中东和非洲国家

第八章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和分销通路合作伙伴（根据现有资讯）
  • 市场占有率和市场定位分析（基于现有资讯）
  • 供应商情况（基于现有资讯）
  • 策略规划

第九章：公司简介

  • 主要公司的市占率分析
  • 公司简介
    • Alliance Pharma PLC
    • MoLnlycke Health Care AB
    • Smith & Nephew
    • Newmedical Technology Inc
    • RejAfAVaskin
    • Sonoma PharmaceuticalsInc
    • Suneva Medical
    • HRA Pharma
    • Lumenis
    • Perrigo Company Plc
简介目录
Product Code: VMR11210559

The Hypertrophic And Keloid Scar Treatment Market size is expected to reach USD 25.65 Billion in 2034 from USD 9.24 Billion (2025) growing at a CAGR of 12.02% during 2026-2034.

The Global Hypertrophic and Keloid Scar Treatment Market has expanded due to increasing awareness of cosmetic and dermatological treatments. Rising incidence of surgical procedures, burns, and traumatic injuries has contributed to greater demand for scar management solutions. Advances in minimally invasive procedures and laser therapies have improved treatment outcomes. Growing consumer focus on aesthetic appearance further supports market growth.

Key growth drivers include technological advancements in corticosteroid injections, cryotherapy, silicone gel sheets, and laser-based treatments. The increasing availability of dermatology clinics and aesthetic centers worldwide has enhanced access to specialized care. Social media influence and rising disposable incomes also encourage consumers to seek cosmetic treatments. Additionally, ongoing research into regenerative medicine is expanding therapeutic options.

Looking ahead, the market is expected to grow steadily with continuous innovation in non-invasive and combination therapies. Emerging markets offer strong growth potential due to expanding healthcare infrastructure. Increasing investment in dermatology research will enhance product development. As patient demand for effective and affordable scar treatments rises, the market will continue to evolve.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Scar Type

  • Hypertrophic
  • Keloid

By Product Type

  • Topical Laser Products
  • Products
  • Injectables
  • Other

By End User

  • Hospitals
  • Clinics
  • Others

COMPANIES PROFILED

  • Alliance Pharma PLC, Mlnlycke Health Care AB, Smith Nephew, Newmedical Technology Inc, Rejvaskin, Sonoma Pharmaceuticals, Inc, Suneva Medical, HRA Pharma, Lumenis, Perrigo Company plc

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL HYPERTROPHIC AND KELOID SCAR TREATMENT MARKET: BY SCAR TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Scar Type
  • 4.2. Hypertrophic Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Keloid Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HYPERTROPHIC AND KELOID SCAR TREATMENT MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Product Type
  • 5.2. Topical Laser Products Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Products Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Injectables Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HYPERTROPHIC AND KELOID SCAR TREATMENT MARKET: BY END USER 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End User
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HYPERTROPHIC AND KELOID SCAR TREATMENT MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Scar Type
    • 7.2.2 By Product Type
    • 7.2.3 By End User
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Scar Type
    • 7.3.2 By Product Type
    • 7.3.3 By End User
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Scar Type
    • 7.4.2 By Product Type
    • 7.4.3 By End User
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Scar Type
    • 7.5.2 By Product Type
    • 7.5.3 By End User
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Scar Type
    • 7.6.2 By Product Type
    • 7.6.3 By End User
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL HYPERTROPHIC AND KELOID SCAR TREATMENT INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Alliance Pharma PLC
    • 9.2.2 MA¶Lnlycke Health Care AB
    • 9.2.3 Smith & Nephew
    • 9.2.4 Newmedical Technology Inc
    • 9.2.5 RejAfAVaskin
    • 9.2.6 Sonoma PharmaceuticalsInc
    • 9.2.7 Suneva Medical
    • 9.2.8 HRA Pharma
    • 9.2.9 Lumenis
    • 9.2.10 Perrigo Company Plc